The deficit between cost and value widened by £4,787 to £96,187 and portfolio value dropped to £110,070.
Worst performer was SAE:Simec Atlantis Energy falling 13%, but we don't care about that and it made no difference to my holding which is 84% down.
EDV:Endeavour Mining sacked their CEO and fell 10% as a result, which is about twice as much as they would have fallen if they followed the pattern of everything else
AJB:AJ Bell and FXPO:Ferrexpo both fell 8%.
IPX:Impax Asset Management fell 7% and into loss.
ASHM:Ashmore Group, BLU:Blue Star Capital, III:3i Group, JLP:Jubilee Metals, OPTI:Optibiotix and PAF:Pan African Resources all fell 6% and include some of my biggest holdings.
CAML:Cental Asia Metals, CEY:Centamin, GAW:Games Workshop and PAGE:Pagegroup all fell 5%.
RDT:Rosslyn Data climbed 8%, but my holding remains 102% down and doomed.
Share of the Week was SBTX:SkinBioTherapeutics which bucked the trend and climbed 14% for absolutely no discernible reason. There is still no sign of any positive news and chances are they are going to issue loads of shares or borrow loads of money to acquire 2 new companies which could see them collapse. I can't understand why they don't wait for their existing products to generate revenue before they go looking for things to buy, unless they don't think their existing products will make revenue. Never mind, not complaining while they are on the up.
Here's the ISA and shares portfolio after week 23 of year 9.
| Weekly Change | |||
| Cash | £151.99 | +£0.25 | |
| Portfolio cost | £99,175.93 | +£0 | |
| Portfolio sell value (bid price-commission) | £51,110.46 | (-48.5%) | -£1,958.78 |
| Potential profits | £1,941.32 | -£427.31 | |
| Yr 9 Dividends | £202.72 | +£0 | |
| Yr 9 Interest | £2.71 | +£0.25 | |
| Yr 9 Profit from sales | £31.44 | +£0 | |
| Yr 9 proj avg monthly profit | £38.10 | (0.6%) | -£1.68 |
| Total Dividends | £12,114.15 | +£0 | |
| Total Interest | £4.64 | +£0.25 | |
| Total Profit from sales | £17,329.97 | +£0 | |
| Average monthly cash profit | £286.61 | (4.9%) | -£0.65 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Compound performance | 41% | +0% |
The portfolio value actually dropped by less than it went up last week, so despite feeling bleak it could be worse. Potential profits took a hit and GAW:Games Workshop went to loss, and I had 25p interest from AJ Bell.
Not nice to see.
Now heading in entirely the opposite direction to the trend line.
The SIPP looks like this after week 423 overall and week 7 of year 9.
| Weekly Change | ||||
| Cash | £836.29 | +£250.94 | ||
| Portfolio cost | £104,017.65 | +£0 | ||
| Portfolio sell value (bid price - commission) | £56,635.06 | (-45.6%) | -£2,820.32 | |
| Potential profits | £767.01 | -£433.60 | ||
| Yr 9 Dividends | £70.36 | +£0 | ||
| Yr 9 Interest | £0.94 | +£0.94 | ||
| Yr 9 Profit from sales | £3,373.97 | +£0 | ||
| Yr 9 proj avg monthly profit | £2,121.55 | (36.9%) | -£352.91 | |
| Total Dividends | £14,705.24 | +£0 | ||
| Total Interest | £6.87 | +£0.94 | ||
| Total Profit from sales | £14,209.87 | +£0 | ||
| Average monthly cash profit | £284.24 | (4.9%) | -£0.67 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 40% | +0% |
Cash went up as I added my monthly investment but it won't deal until next week, and also added 94p interest from AJ Bell. Portfolio value was hammered way more than it went up last week, and potential profits dived as several profitable shares went to loss.
Will we ever reach that injection line?
Very bad indeed.
The trading account looks like this after week 389 overall and week 25 of year 8.
| Weekly Change | |||
| Cash | £141.20 | +£0 | |
| Portfolio cost | £1,935.11 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,195.90 | (-38.2%) | -£8.47 |
| Potential profits | £0 | +£0 | |
| Year 8 Dividends | £8.56 | +£0 | |
| Year 8 Interest | £0 | +£0 | |
| Year 8 Profit | £283.99 | +£0 | |
| Yr 8 proj avg monthly profit | £50.71 | (+31.4%) | -£2.11 |
| Dividends | £68.66 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£646.70 | +£0 | |
| Average monthly cash profit | -£6.44 | (-4.0%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
SBTX:SkinBioTherapeutics soared, but I don't have many, and BARC:Barclays went up a bit, but with 2 lots of JLP:Jubilee Metals dropping 6%, the result was a red week, but only by £8.
Still pretty flat looking
No longer parallel with the trend line which is likely to change direction when we lose the lows from almost a year ago.
Let's hope this week won't be a trend for 2024, as it feels like a dreadful start to the year when so many of my "safe" shares dropped so heavily. They're not meant to move that much in a week.
I want to buy some more magic formula shares in my SIPP, but my January contribution is about £170 off the minimum to do a transfer. My only hope is the bond fund goes up by 10% by then else I'll be waiting until late February. I have some profitable JLP:Jubilee Metals shares that I could sell and liberate £2,362 but I'd only make £228 profit and I feel these are due a significant re-rate. I'd rather hold for 12p which would give me £2,614 profit and liberate £4,748, but that might be wishful thinking!
Meanwhile we still wait in vain for news from OPTI:Optibiotix. I have a feeling it's never going to come, and if it does, I bet it's a damp squib for some niche product likely to generate no revenue, like the cookies in Wallmart and Costco that we got so excited about a few years ago and turned out to be utterly valueless.
Meanwhile we still wait in vain for news from OPTI:Optibiotix. I have a feeling it's never going to come, and if it does, I bet it's a damp squib for some niche product likely to generate no revenue, like the cookies in Wallmart and Costco that we got so excited about a few years ago and turned out to be utterly valueless.
No comments:
Post a Comment